Health Invest Partners Ab Krystal Biotech, Inc. Transaction History
Health Invest Partners Ab
- $208 Million
- Q4 2024
A detailed history of Health Invest Partners Ab transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Health Invest Partners Ab holds 9,202 shares of KRYS stock, worth $1.43 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
9,202
Previous 9,202
-0.0%
Holding current value
$1.43 Million
Previous $1.67 Million
13.87%
% of portfolio
0.69%
Previous 0.81%
Shares
4 transactions
Others Institutions Holding KRYS
# of Institutions
308Shares Held
24.5MCall Options Held
506KPut Options Held
383K-
Black Rock Inc. New York, NY3.95MShares$615 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$448 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$409 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$199 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$154 Million9.67% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...